Other News To Note

 Aerpio Therapeutics Inc., of Cincinnati, said collaborators from Massachusetts General Hospital, Harvard Medical School, New York University and the Massachusetts Institute of Technology published data on its Tie2 activator, AKB-9778, in the Journal of the National Cancer Institute.